Fabry Disease Nephropathy: Histological Changes With Nonclassical Mutations and Genetic Variants of Unknown Significance.

Chronic kidney disease Fabry disease Fabry nephropathy enzymatic replacement therapy glomerulosclerosis interstitial fibrosis kidney biopsy lysosomal storage disease podocyte vacuoles proteinuria α-GAL A

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 26 04 2022
accepted: 12 03 2023
pubmed: 11 6 2023
medline: 11 6 2023
entrez: 10 6 2023
Statut: ppublish

Résumé

Fabry disease (FD) is an X-linked genetic disorder that causes lysosomal storage of glycosphingolipids, primarily globotriaosylceramide (Gb3) and its derivative globotriaosylsphingosine (lyso-Gb3), with multiorgan dysfunction including chronic kidney disease. Affected individuals may be carriers of gene variants that are of uncertain significance (GVUS). We describe kidney pathology at the early stages of FD-related kidney disease to gain insights into its association with GVUS and sex. Single-center, case series. Thirty-five consecutively biopsied patients (aged 48.1±15.4 years, 22 females) from among 64 patients with genetically diagnosed FD. Biopsies were retrospectively screened using the International Study Group of Fabry Nephropathy Scoring System. Genetic mutation type, p.N215S and D313Y, sex, age, estimated glomerular filtration rate (eGFR), plasma lyso-Gb3 (pLyso-Gb3) levels, and histological parameters, including Gb3 deposits were recorded. Genetic analyses showed mostly missense mutations, p.N215S variant in 15, and the "benign polymorphism" D313Y in 4 of the biopsied patients. Morphological lesions were similar for men and women except for interstitial fibrosis and arteriolar hyalinosis being more common in men. Early in their clinical course, patients with normal/mild albuminuria had podocyte, tubular, and peritubular capillary vacuoles/inclusions, and evidence of chronicity, i.e., glomerulosclerosis, interstitial fibrosis, tubular atrophy. These findings appeared to be associated with pLyso-Gb3, eGFR, and age. Retrospective design and inclusion of outpatients partially based on family pedigree. In early stages of kidney disease in the setting of FD, numerous histological abnormalities are present. These observations suggest that kidney biopsies early in FD may reveal activity of kidney involvement that may inform clinical management.

Identifiants

pubmed: 37301502
pii: S0272-6386(23)00655-8
doi: 10.1053/j.ajkd.2023.03.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

581-596.e0

Informations de copyright

Copyright © 2023 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Marisa Santostefano (M)

Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; Alma Mater Studiorum, University of Bologna, Bologna.

Maria Cappuccilli (M)

Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; Alma Mater Studiorum, University of Bologna, Bologna.

Dino Gibertoni (D)

Research and Innovation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.

Benedetta Fabbrizio (B)

Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.

Deborah Malvi (D)

Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.

Marcello Demetri (M)

Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.

Irene Capelli (I)

Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; Alma Mater Studiorum, University of Bologna, Bologna.

Edoardo Tringali (E)

Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; Alma Mater Studiorum, University of Bologna, Bologna.

Valentina Papa (V)

Department of Biomedical and Neuromotor Sciences, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna.

Elena Biagini (E)

Cardiology, University of Bologna, Bologna.

Giovanna Cenacchi (G)

Biotechnology and Methods in Laboratory Medicine, University of Bologna, Bologna.

Adriana Galdi (A)

Department of Internal Medicine, S.S. Annunziata Hospital, University of Ferrara, Cento, Italy.

Vincenzo Donadio (V)

Neuromuscular and Neuroimmunology Unit, Bellaria Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.

Rocco Liguori (R)

Neuromuscular and Neuroimmunology Unit, Bellaria Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.

Giorgio Zoli (G)

Department of Internal Medicine, S.S. Annunziata Hospital, University of Ferrara, Cento, Italy.

Gaetano La Manna (G)

Nephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; Alma Mater Studiorum, University of Bologna, Bologna. Electronic address: gaetano.lamanna@unibo.it.

Gianandrea Pasquinelli (G)

Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; Biotechnology and Methods in Laboratory Medicine, University of Bologna, Bologna.

Classifications MeSH